Publicacións en colaboración con investigadores/as de University of Western Australia (2)

2014

  1. Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: Quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine

    Annals of Oncology, Vol. 25, Núm. 7, pp. 1428-1436

2012

  1. Dabrafenib in BRAF-mutated metastatic melanoma: A multicentre, open-label, phase 3 randomised controlled trial

    The Lancet, Vol. 380, Núm. 9839, pp. 358-365